Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$811K Sell
3,731
-87
-2% -$19.3K 0.05% 157
2025
Q4
$872K Sell
3,818
-83
-2% -$18.9K 0.05% 146
2025
Q3
$903K Sell
3,901
-144
-4% -$29.3K 0.06% 140
2025
Q2
$751K Buy
4,045
+140
+4% +$26K 0.05% 157
2025
Q1
$818K Sell
3,905
-3
-0.1% -$583 0.06% 135
2024
Q4
$694K Buy
3,908
+376
+11% +$69.1K 0.05% 149
2024
Q3
$698K Sell
3,532
-16
-0.5% -$2.99K 0.06% 154
2024
Q2
$609K Sell
3,548
-136
-4% -$22.5K 0.05% 170
2024
Q1
$670K Buy
3,684
+100
+3% +$17.2K 0.06% 151
2023
Q4
$555K Buy
3,584
+101
+3% +$14.7K 0.09% 142
2023
Q3
$519K Hold
3,483
0.1% 145
2023
Q2
$469K Sell
3,483
-35
-1% -$5.13K 0.09% 155
2023
Q1
$561K Sell
3,518
-17
-0.5% -$2.6K 0.11% 143
2022
Q4
$571K Sell
3,535
-274
-7% -$42K 0.13% 132
2022
Q3
$511K Sell
3,809
-13
-0.3% -$1.86K 0.13% 137
2022
Q2
$585K Buy
3,822
+101
+3% +$15.4K 0.15% 118
2022
Q1
$603K Buy
3,721
+1,892
+103% +$275K 0.14% 119
2021
Q4
$248K Buy
+1,829
New +$216K 0.09% 125

Other funds holding ABBV

NFP Retirement Inc's ABBV Position: Q1 2026 in Review

NFP Retirement Inc reduced its AbbVie (ABBV) stake by 2.3% in Q1 2026, selling an estimated $19.3K and leaving 3,731 shares worth $811K. The position accounts for 0.05% of the portfolio, ranked #157.

NFP Retirement Inc first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $903K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • NFP Retirement Inc held 3,731 shares of AbbVie worth $811K as of Q1 2026.
  • NFP Retirement Inc sold 87 AbbVie shares in Q1 2026, an estimated $19.3K.
  • AbbVie made up 0.05% of NFP Retirement Inc's portfolio in Q1 2026, its #157 holding.
  • NFP Retirement Inc first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • NFP Retirement Inc's AbbVie position peaked at $903K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on NFP Retirement Inc's 13F filing for Q1 2026, filed 13 May 2026.